Original Article

Split Viewer

Hip Pelvis 2023; 35(4): 268-276

Published online December 31, 2023

https://doi.org/10.5371/hp.2023.35.4.268

© The Korean Hip Society

Surgical Resection of Neurogenic Heterotopic Ossification around Hip Joint in Stroke Patients: A Safety and Outcome Report

Jae-Young Beom, MD , WengKong Low, MD* , Kyung-Soon Park, MD, PhD , Taek-Rim Yoon, MD, PhD , Chan Young Lee, MD , Hyeongmin Song, MD

Department of Orthopedic Surgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea
Orthopaedic and Traumatology Department, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia*

Correspondence to : Kyung-Soon Park, MD, PhD
(https://orcid.org/0000-0002-5036-1803)
Department of Orthopaedic Surgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, 322 Seoyang-ro, Hwasun-eup, Hwasun 58128, Korea
TEL: +82-62-670-9475
E-mail: chiasma@hanmail.net

Jae-Young Beom and WengKong Low contributed equally to this study as co-first authors.

Received: January 10, 2023; Revised: June 14, 2023; Accepted: June 15, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Purpose: Resection remains the most reliable treatment for established heterotopic ossification, despite questions regarding its effectiveness due to the potential for complications. This study evaluated the clinical outcomes and complications of neurogenic heterotopic ossification (NHO) resection in stroke patients’ ankylosed hips.
Materials and Methods: We retrospectively analyzed nine hip NHO resections performed on seven patients from 2010 to 2018. The pre- and postoperative range of motion of the operated hip were compared. Analysis of postoperative complications, including infection, recurrence, iatrogenic fracture, and neurovascular injury was performed.
Results: The mean operative time was 132.78±21.08 minutes, with a mean hemoglobin drop of 3.06±0.82 g/dL within the first postoperative week. The mean duration of postoperative follow-up was 52.08±28.72 months for all patients. Postoperative range of motion showed improvement from preoperative. Flexion and external rotation (mean, 58.89±30.60°and 16.67±18.03°, respectively) showed the greatest gain of motion of the operated hip joint. Postoperative infections resolved in two cases through surgical debridement, and one case required conversion to total hip arthroplasty due to instability. There were no recurrences, iatrogenic fractures, or neurovascular injuries.
Conclusion: Resection is a beneficial intervention for restoring the functional range of motion of the hip in order to improve the quality of life for patients with NHO and neurological disorders. We recommend performance of a minimal resection to achieve a targeted functional arc of motion in order to minimize the risk of postoperative complications.

Keywords Heterotopic ossification, Hip joint, Stroke, Neurogenic arthropathy

Neurogenic heterotopic ossification (NHO), which is characterized by aberrant formation of ectopic bone in the soft tissue, typically around a joint, occurs in patients who have sustained neurological trauma. NHO includes central nervous system damage, which is most common in cases of traumatic brain or spinal cord injury, with an incidence rate for NHO of 20-30%1,2,3,4,5). Atraumatic insults to the central nervous system associated with pathogenesis of NHO include cerebrovascular accident, cerebral anoxia, and brain tumors2,6,7,8). However, occurrence of NHO is rare in stroke patients; Varghese reported an incidence of 0.5-1.2%9), however, a recent multicenter cross-sectional study of 17,794 stroke patients conducted in 2019 by Cunha et al.10) reported that the incidence of clinically and radiologically apparent NHO was 1.3% during a 10-year period. Risk factors for NHO in this patient group include hemorrhagic or hemorrhagic deformable ischemic stroke, severity of early neurological lesions, and spasmodic and cognitive impairment7,10).

The hip joint is most commonly affected by NHO2,11), followed by NHO in other large joints12,13). Patients generally develop fever, pain, swelling, and erythema around the affected joint and, if untreated, these symptoms can progress to an established heterotopic ossification (HO) that can lead to joint stiffness or even ankylosis wherein the stiff or ankylosed hip joint is fixed in a non-functional position, which can impede nursing care, including hygiene care and obtaining a stable sitting posture. In advanced cases, NHO can lead to development of ulcers that can have additional adverse effects on the patients’ quality of life.

Despite various surgical complications, including excessive bleeding, infection, recurrence, binary fractures, and neurovascular damage, resection remains the only proven treatment for NHO5,6,14,15,16,17). Thus there are questions regarding the appropriateness of resection in management of NHO. The aim of this study was to evaluate the clinical outcome and safety of resection of ankylosed hip NHO in stroke patients.

1. Participants

This study was approved by the Institutional Review Board (IRB) of Chonnam National University Hwasun Hospital (IRB No. CNUHH-2022-232). The written informed consent was waived by the IRB due to the retrospective nature of the study. This retrospective single-center cross-sectional study was conducted in order to examine the clinical outcomes and complications of surgical treatment of NHO performed at Chonnam National University Hwasun Hospital from 2010 to 2018. Patients who underwent resection of NHO that occurred after a cerebrovascular accident were included. Our surgical indications were patients who met both of the following conditions: (1) Patients with difficulty in wheelchair ambulation or perineal hygiene care because of an ankylosed hip due to HO, (2) HO is matured. The diagnosis was based on evidence of simple radiographic appearance following exoskeleton formation. A preoperative computed tomography (CT) scan with three-dimensional (3D) reconstruction was used for comprehensive surgical planning, followed by surgical resection of the exoskeleton.

2. Operative Method

All operations were performed by one of the two senior hip surgeons in Chonnam National University Hwasun Hospital. A thorough review of the CT scan was performed by the operating surgeon in order to determine the surgical approach. A Smith-Peterson approach was used in all cases included in this study. The hip joint capsule was preserved as much as possible. Differentiation from normal bone was sometimes impossible due to matured ectopic bone. Therefore, an image intensifier was used to guide the resection, which was halted after the desired functional range of motion had been obtained. Repair of the joint capsule was performed in cases of an unintentional breach. A negative-pressure drain was inserted in all cases to reduce the risk of postoperative hematoma formation. Postoperative monitoring of the hemoglobin level was performed.

For prevention of recurrence, adjuvant radiation therapy was performed within 24 hours after the operation if available. Patients also took etidronate or non-steroidal anti-inflammatory drugs (NSAIDs) medication postoperatively.

3. Follow-up

The patients were observed during follow-up, after the first and third months after discharge, and every six months thereafter. The range of motion was recorded during follow-up, and a plain radiograph of the hip was obtained to monitor for recurrence of HO.

4. Evaluation Methods

The following data were extracted from the electronic medical records of each patient: age, sex, side, location of NHO, severity of NHO according to Brooker grading18), previous history of the hip joint on the affected side such as history of other disease or operation, interval from time of neurological insult to time of resection surgery, and operation-related details, including operating surgeon, surgical approach used, duration of operation, and the maximum hemoglobin decrease within the first postoperative week. The pre- and postoperative range of motion of the operated hip were compared for determination of the clinical outcome and all postoperative complications were documented. Statistical analysis was performed using IBM SPSS Statistical software (ver. 25; IBM), and P<0.05 was considered statistically significant. A comparison of range of motion between the preoperative and postoperative period was performed using a Mann–Whitney test.

From 2010 to 2018, nine hip NHO resections were performed in seven patients (all patients were male); four resections were performed on the right hip and five on the left hip. The mean age of patients in our series was 51.44±9.42 years. All nine hip NHOs occurred after a cerebrovascular accident and none of the patients had previous history such as history of other disease or operation for the hip joint on the affected side. The mean duration of follow-up was 52.08±28.72 months. The mean interval from the cerebrovascular accident to NHO surgery was 36.27±25.61 months. According to the Brooker classification for HO, three cases of NHO were graded as Class III and six cases were graded as Class IV18). Regarding the location of the ectopic bone, all NHOs occurred at the anterior aspect of the hip along the iliopsoas muscle, and additional NHO was detected at the lateral aspect of the hip along the gluteus medius in one case. Details regarding the demographic distribution are shown in Table 1.

In the preoperative physical examination, only a limited range of motion of less than 30° in all motions of the hip joint was observed in seven out of nine cases. Ambulation was only possible in one case. Details regarding the preoperative range of motion and ambulation status are shown in Table 2.

CT scan images obtained preoperatively and plain radiographs obtained after sequential excision surgery in a representative case are shown in Fig. 1.

The mean operative time for NHO surgery was 132.78±21.08 minutes. The hemoglobin drop in the postoperative period was 3.06±0.82 g/dL in the first week. The amount of preoperative transfusion of packed red cells (PRC) was 3.89±2.71 packs, and one pack of PRC was 320 mL. The amount of heterotopic bone removed intraoperatively was 225.89±67.30 g. To prevent recurrence after the operation, all patients took NSAIDs medication per oral. In additional, radiation therapy was administered in two patients, two patients took etidronate medication per oral, two patients received both, and three patients did not receive either one. Detailed postoperative information is shown in Table 3.

The pre- and postoperative range of motion of the operated hip were compared in order to determine the primary outcome of our study. Details regarding the postoperative range of motion are shown in Table 4. Improvement of the total range of motion to 153.89±38.14° was observed postoperatively. The range of motion before and after surgery differed significantly, except for abduction range. Flexion and external rotation showed the most significant gains in range of motion, with mean improvements of 58.89±30.60° and 16.67±18.03°, respectively. This improved functional range of motion was particularly important for achievement of a stable sitting posture as well as for perineal hygiene care. Results on the improvement in the range of motion are shown in Table 5.

There were two cases of postoperative infection in our cohort. The first patient presented with wound dehiscence and oozing after transfer to the ward in the initial postoperative period. The hematoma was identified based on a CT scan (Fig. 2). The second patient presented with late erythema and swelling during subsequent follow-up, and a CT scan confirmed abscess formation with gas at the NHO resection site. In both cases, resolution of the complications was achieved after surgical debridement with insertion of a negative pressure drain and a short course of systemic antibiotics.

In addition, this cohort included one case of late joint instability and subluxation in a patient with relatively few limitations in the range of hip joint motion who was able to stand up with use of a walker during the preoperative physical examination. Despite the initial improvement in range of motion, the patient complained of slowly progressing pain over the operated hip. Progressive subluxation and osteoarthritic changes of the hip were observed on serial plain radiography during the follow-up. The patient underwent a total hip replacement surgery nine years after the initial NHO surgery, which resulted in resolution of the symptoms. There were no cases of recurrence, iatrogenic fracture, or neurovascular injury in our cohort.

Although extensive study has been conducted in recent years, the precise pathophysiology underlying the development of NHO remains unclear15,19), despite growing evidence of the induction of HO via the release of osteoconductive factors, produced by a complex interface between local and systemic conditions that includes the autonomous nervous system and inflammatory responses20,21). There is still no effective preventive intervention for NHO despite the use of a few widely accepted prophylactic methods, including NSAIDs, such as indomethacin and celecoxib22), and radiation therapy23,24). There are questions regarding the effectiveness of prophylactic treatments, and there is considerable variation in the dosage and dosing interval used in different centers.

In patients with established NHO, the limitation of the range of motion of the hip joint can have adverse effects on the patient’s quality of life, causing many difficulties in daily life. Thus far the only effective treatment is resection or total hip arthroplasty3,10,14,25), which, although efficient in recovery of motion in the NHO-involved hip joint, is technically demanding and is associated with a high risk of complications that include excessive bleeding, recurrence, infection, iatrogenic fracture, and neurovascular injuries17).

The earliest incidence of infection following NHO resection was reported by Garland and Orwin16) in 1989, wherein superficial or deep infection was detected postoperatively in 79% (19 out of 24) of operated hips. Two studies by Stover et al.26) and Meiners et al.5) reported postoperative infection rates of 9% and 12% in 42 and 41 hips, respectively. A more recent study by Gatin et al.4) in 2017 reported an overall postoperative infection rate of 10%, of which 22% of cases occurred in patients with spinal cord injury and 5% in patients with other causes of NHO. We observed a rate of postoperative infection of 22% in our study group, which is comparable to those reported by other authors.

Postoperative recurrence of HO is a problematic complication for the patients and can be worrisome for the treating surgeon. Garland and Orwin16) reported a recurrence rate of 86% in their study conducted in 1989, whereas Almangour et al.14) reported a much lower recurrence rate of 5.6% in their more recent study conducted in 2016. This wide range is the result of a lack of consensus on the definition of recurrence14). Waiting for the ectopic bone to mature prior to resection by monitoring the patient’s symptoms and the serial plain radiography is the common practice. Alternatively, bone scintigraphy, a sensitive examination for detecting HO, which is widely accepted as an effective method for determining the maturity of the ectopic bone, can facilitate planning of the excision timing27,28). However, according to findings from recent studies, the risk of recurrence is independent of the timing of surgery6,14,29). Early performance of an operation is feasible, and surgery should not be unduly delayed while waiting to observe a “cold” lesion on bone scintigraphy. In our series, bone scintigraphy was not performed to determine the maturity of the NHO, and resection was planned and performed as soon as NHO had caused significant functional interference in posture or the nursing process for the patient.

Nevertheless, development of a clear goal for each patient before the surgical removal of NHO is important. The targeted range of motion that should be achieved during the resection surgery should be determined by the operating surgeon. Thorough preoperative planning based on CT scans can guide the surgeon with regard to the target amount of ectopic bone to be removed to obtain the range of motion required for achievement of functional improvement. A complete resection of all ectopic bones, as used in the oncological approach, unnecessarily increases morbidity without additional advantage to the patient and should therefore be avoided15). Besides increasing the risk of bleeding, the resulting larger dead space can lead to hematoma formation and increased risk of infection. In addition, there may also be a risk of iatrogenic fracture or joint instability.

One case of late instability following NHO resection that eventually required a total hip replacement was identified in our cohort. We believe that the instability was a result of overzealous removal of ectopic bone, as matured ectopic bone is indistinguishable from the underlying normal bone3). Under the guidance of the image intensifier, assessment of the intraoperative range of motion by the operating surgeon is important, and resection should be halted when the desired range of motion has been achieved.

No cases of recurrence, iatrogenic fracture, or neurovascular injury were observed in our study group, which we attribute to use of meticulous surgical technique and conduct of detailed preoperative planning for each patient. It is interesting to note that our cohort includes two stroke patients with bilateral hip NHO. Development of NHO on the non-paretic side was uncommon and was barely discussed in case reports30), until a recent study published in 2019, wherein Cunha et al.10) reported an incidence of bilateral NHO of 0.2% in 17,794 stroke patients who were included in their study. In our study, to minimize the risk of excessive intraoperative bleeding, resection of bilateral hip NHO was performed in a sequential setting with an interval of 3-6 months.

One limitation of this study is the relatively small sample size, which can be attributed in part to the retrospective study design, as some of the patient data were missing and some patients were lost to follow-up. However, because only a few studies on NHO resection in stroke patients have been reported, we believe that the results of this study provide a framework for designing future studies and will be helpful in determining the policy for treating rare cases of NHO in stroke patients.

In conclusion, NHO resection in stroke patients is a beneficial and effective surgery for recovering functional range of motion of the hip and improving quality of life in patients with neurological disorders. To minimize the potential risk of operative complications, we recommend performance of a minimal resection surgery to achieve the desired functional range of motion over a complete removal of the ectopic bone.

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.
Fig. 1.

(A, B) Preoperative plain radiograph and computed tomography scan of a stroke patient with left hip neurogenic heterotopic ossification. (C, D) Immediate operation plain radiograph and clinical photo of removed heterotopic ossification. (E) Follow-up plain radiograph taken one year after surgery.


Fig. 2.

(A) Preoperative plain radiograph of a stroke patient with bilateral hip neurogenic heterotopic ossification. (B) Immediate operation plain radiograph. (C, D) Computed tomography scan performed two weeks after surgery showing hematoma formation.


Demographic Distribution of NHO Patients
Case No.SexAge (yr)SideCausePHx of affected side hip jointFollow-up duration (mo)Interval to operation (mo)Brooker classificationHO locationSurgical approach
1M47RCVANone56.3048.73IVIliopsoas and gluteus mediusSmith-Peterson
2M47LCVANone58.8746.17IIIIliopsoasSmith-Peterson
3M61RCVANone40.2311.37IVIliopsoasSmith-Peterson
4M61LCVANone33.3318.27IVIliopsoasSmith-Peterson
5M42LCVANone24.6092.47IIIIliopsoasSmith-Peterson
6M36LCVANone122.7731.97IVIliopsoasSmith-Peterson
7M37RCVANone52.5044.87IVIliopsoasSmith-Peterson
8M48LCVANone39.1016.27IVIliopsoasSmith-Peterson
9M64RCVANone41.0016.33IIIIliopsoasSmith-Peterson
Mean51.44±9.4252.08±28.7236.27±25.61

NHO: neurogenic heterotopic ossification, M: male, R: right, L: left, CVA: cerebrovascular accident, PHx: past history, HO: heterotopic ossification.


Preoperative ROM and Ambulation Status of NHO Patients
Case No.Flexion (°)Extension (°)Internal rotation (°)External rotation (°)Abduction (°)Adduction (°)Total ROM (°)Ambulation status
130–30–2020000Wheelchair
230–3000000Wheelchair
310–10005510Bed-ridden
400005510Bed-ridden
5700010205105Ambulation with support
620–2000000Bed-ridden
760–3010010050Wheelchair
830–30–303015–150Wheelchair
9300040300105Wheelchair

ROM: range of motion, NHO: neurogenic heterotopic ossification.


Intraoperative and Postoperative Information of NHO Patients
Case No.Operation time (min)Hemoglobin drop (g/dL)PRC transfusion (pack)Resection amount (g)Postop RTPostop etidronatePostop NSAIDsComplication
11053.36320YesYesYesNone
21202.50190YesYesYesNone
31652.98220NoYesYesInfection
414037180NoNoYesNone
51603.12170NoNoYesNone
61451.54260YesNoYesNone
71253.44310YesNoYesInstability
81254.61263NoNoYesInfection
91103.23120NoYesYesNone
Mean132.78±21.083.06±0.823.89±2.71225.89±67.30

NHO: neurogenic heterotopic ossification, PRC: packed red cells, Postop: postoperative, RT: radiation therapy, NSAIDs: non-steroidal anti-inflammatory drugs.


Postoperative ROM of NHO Patients
Case No.Flexion (°)Extension (°)Internal rotation (°)External rotation (°)Abduction (°)Adduction (°)Total ROM (°)
1100010301020170
2110010301020180
390010303015185
49005303015180
5120010403010315
61000030200150
7600101005135
890051055115
95001040300230

ROM: range of motion, NHO: neurogenic heterotopic ossification.


Improvement in ROM of NHO Patients
PreoperativePostoperativeImprovementP-value
Flexion (°)31.11±22.0590.00±22.3658.89±30.600.000
Extension (°)–16.67±14.140.00±0.0016.67±14.140.014
Internal rotation (°)–4.44±12.367.78±3.6312.22±12.280.004
External rotation (°)11.11±15.3727.78±10.9316.67±18.030.024
Abduction (°)9.44±10.4418.33±12.258.89±13.410.136
Adduction (°)0.00±6.1210.00±7.9110.00±8.290.019
Total ROM (°)30.56±43.76184.44±58.97153.89±38.140.000

The P-values are of inter-group comparisons, with P<0.05 indicating significance.

ROM: range of motion, NHO: neurogenic heterotopic ossification.


  1. Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002;43:346-353.
    Pubmed
  2. Cipriano CA, Pill SG, Keenan MA. Heterotopic ossification following traumatic brain injury and spinal cord injury. J Am Acad Orthop Surg 2009;17:689-697.
    Pubmed CrossRef
  3. Brady RD, Shultz SR, McDonald SJ, O’Brien TJ. Neurological heterotopic ossification: current understanding and future directions. Bone 2018;109:35-42.
    Pubmed CrossRef
  4. Gatin L, Genêt F, Dinh A, Denormandie P. Postoperative infections after excision of neurogenic heterotopic ossifications at the hip: risk factors and causative organisms. Orthop Traumatol Surg Res 2017;103:357-361.
    Pubmed CrossRef
  5. Meiners T, Abel R, Böhm V, Gerner HJ. Resection of heterotopic ossification of the hip in spinal cord injured patients. Spinal Cord 1997;35:443-445.
    Pubmed CrossRef
  6. Denormandie P, de l’Escalopier N, Gatin L, Grelier A, Genêt F. Resection of neurogenic heterotopic ossification (NHO) of the hip. Orthop Traumatol Surg Res 2018;104:S121-S127.
    Pubmed CrossRef
  7. Genêt F, Minooee K, Jourdan C, Ruet A, Denormandie P, Schnitzler A. Troublesome heterotopic ossification and stroke: features and risk factors. A case control study. Brain Inj 2015;29:866-871.
    Pubmed CrossRef
  8. Hajek VE. Heterotopic ossification in hemiplegia following stroke. Arch Phys Med Rehabil 1987;68:313-314.
    Pubmed
  9. Varghese G, Williams K, Desmet A, Redford JB. Nonarticular complication of heterotopic ossification: a clinical review. Arch Phys Med Rehabil 1991;72:1009-1013.
    Pubmed CrossRef
  10. Cunha DA, Camargos S, Passos VMA, Mello CM, Vaz LS, Lima LRS. Heterotopic ossification after stroke: clinical profile and severity of ossification. J Stroke Cerebrovasc Dis 2019;28:513-520.
    Pubmed CrossRef
  11. van Kuijk AA, Geurts AC, van Kuppevelt HJ. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord 2002;40:313-326.
    Pubmed CrossRef
  12. Wharton GW, Morgan TH. Ankylosis in the paralyzed patient. J Bone Joint Surg Am 1970;52:105-112.
    Pubmed
  13. Allard MM, Thomas RL, Nicholas RW. Myositis ossificans: an unusual presentation in the foot. Foot Ankle Int 1997;18:39-42.
    Pubmed CrossRef
  14. Almangour W, Schnitzler A, Salga M, Debaud C, Denormandie P, Genêt F. Recurrence of heterotopic ossification after removal in patients with traumatic brain injury: a systematic review. Ann Phys Rehabil Med 2016;59:263-269.
    Pubmed CrossRef
  15. de l’Escalopier N, Salga M, Gatin L, Genêt F, Denormandie P. Resection of heterotopic ossification around the hip after trauma. EFORT Open Rev 2019;4:263-268.
    Pubmed CrossRef
  16. Garland DE, Orwin JF. Resection of heterotopic ossification in patients with spinal cord injuries. Clin Orthop Relat Res 1989;:169-176.
  17. Macheras GA, Lepetsos P, Leonidou A, Anastasopoulos PP, Galanakos SP, Tsiridis E. Results from the surgical resection of severe heterotopic ossification of the hip: a case series of 26 patients. Eur J Orthop Surg Traumatol 2017;27:1097-1102.
    Pubmed CrossRef
  18. Brooker AF, Bowerman JW, Robinson RA, Riley LH. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973;55:1629-1632.
    Pubmed
  19. Genêt F, Kulina I, Vaquette C, et al. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle. J Pathol 2015;236:229-240.
    Pubmed CrossRef
  20. Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 1990;72:1144-1149.
    Pubmed CrossRef
  21. Sullivan MP, Torres SJ, Mehta S, Ahn J. Heterotopic ossification after central nervous system trauma: a current review. Bone Joint Res 2013;2:51-57.
    Pubmed CrossRef
  22. Baird EO, Kang QK. Prophylaxis of heterotopic ossification - an updated review. J Orthop Surg Res 2009;4:12.
    Pubmed CrossRef
  23. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys 2006;65:1289-1299.
    Pubmed CrossRef
  24. Pellegrini VD, Gregoritch SJ. Preoperative irradiation for prevention of heterotopic ossification following total hip arthroplasty. J Bone Joint Surg Am 1996;78:870-881.
    Pubmed CrossRef
  25. Genêt F, Jourdan C, Schnitzler A, et al. Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries. PLoS One 2011;6:e16632.
    Pubmed CrossRef
  26. Stover SL, Niemann KM, Tulloss JR. Experience with surgical resection of heterotopic bone in spinal cord injury patients. Clin Orthop Relat Res 1991;:71-77.
  27. Tyler JL, Derbekyan V, Lisbona R. Early diagnosis of myositis ossificans with Tc-99 m diphosphonate imaging. Clin Nucl Med 1984;9:256-258.
    Pubmed CrossRef
  28. Drane WE. Myositis ossificans and the three-phase bone scan. AJR Am J Roentgenol 1984;142:179-180.
    Pubmed CrossRef
  29. Genêt F, Ruet A, Almangour W, Gatin L, Denormandie P, Schnitzler A. Beliefs relating to recurrence of heterotopic ossification following excision in patients with spinal cord injury: a review. Spinal Cord 2015;53:340-344.
    Pubmed CrossRef
  30. Kocaağa Z, Bal S, Gurgan A. Hemiplegia and heterotopic ossification on the non-paretic extremity: a case report. J Rehabil Med 2007;39:500-502.
    Pubmed CrossRef

Article

Original Article

Hip Pelvis 2023; 35(4): 268-276

Published online December 31, 2023 https://doi.org/10.5371/hp.2023.35.4.268

Copyright © The Korean Hip Society.

Surgical Resection of Neurogenic Heterotopic Ossification around Hip Joint in Stroke Patients: A Safety and Outcome Report

Jae-Young Beom, MD , WengKong Low, MD* , Kyung-Soon Park, MD, PhD , Taek-Rim Yoon, MD, PhD , Chan Young Lee, MD , Hyeongmin Song, MD

Department of Orthopedic Surgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea
Orthopaedic and Traumatology Department, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia*

Correspondence to:Kyung-Soon Park, MD, PhD
(https://orcid.org/0000-0002-5036-1803)
Department of Orthopaedic Surgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, 322 Seoyang-ro, Hwasun-eup, Hwasun 58128, Korea
TEL: +82-62-670-9475
E-mail: chiasma@hanmail.net

Jae-Young Beom and WengKong Low contributed equally to this study as co-first authors.

Received: January 10, 2023; Revised: June 14, 2023; Accepted: June 15, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose: Resection remains the most reliable treatment for established heterotopic ossification, despite questions regarding its effectiveness due to the potential for complications. This study evaluated the clinical outcomes and complications of neurogenic heterotopic ossification (NHO) resection in stroke patients’ ankylosed hips.
Materials and Methods: We retrospectively analyzed nine hip NHO resections performed on seven patients from 2010 to 2018. The pre- and postoperative range of motion of the operated hip were compared. Analysis of postoperative complications, including infection, recurrence, iatrogenic fracture, and neurovascular injury was performed.
Results: The mean operative time was 132.78±21.08 minutes, with a mean hemoglobin drop of 3.06±0.82 g/dL within the first postoperative week. The mean duration of postoperative follow-up was 52.08±28.72 months for all patients. Postoperative range of motion showed improvement from preoperative. Flexion and external rotation (mean, 58.89±30.60°and 16.67±18.03°, respectively) showed the greatest gain of motion of the operated hip joint. Postoperative infections resolved in two cases through surgical debridement, and one case required conversion to total hip arthroplasty due to instability. There were no recurrences, iatrogenic fractures, or neurovascular injuries.
Conclusion: Resection is a beneficial intervention for restoring the functional range of motion of the hip in order to improve the quality of life for patients with NHO and neurological disorders. We recommend performance of a minimal resection to achieve a targeted functional arc of motion in order to minimize the risk of postoperative complications.

Keywords: Heterotopic ossification, Hip joint, Stroke, Neurogenic arthropathy

INTRODUCTION

Neurogenic heterotopic ossification (NHO), which is characterized by aberrant formation of ectopic bone in the soft tissue, typically around a joint, occurs in patients who have sustained neurological trauma. NHO includes central nervous system damage, which is most common in cases of traumatic brain or spinal cord injury, with an incidence rate for NHO of 20-30%1,2,3,4,5). Atraumatic insults to the central nervous system associated with pathogenesis of NHO include cerebrovascular accident, cerebral anoxia, and brain tumors2,6,7,8). However, occurrence of NHO is rare in stroke patients; Varghese reported an incidence of 0.5-1.2%9), however, a recent multicenter cross-sectional study of 17,794 stroke patients conducted in 2019 by Cunha et al.10) reported that the incidence of clinically and radiologically apparent NHO was 1.3% during a 10-year period. Risk factors for NHO in this patient group include hemorrhagic or hemorrhagic deformable ischemic stroke, severity of early neurological lesions, and spasmodic and cognitive impairment7,10).

The hip joint is most commonly affected by NHO2,11), followed by NHO in other large joints12,13). Patients generally develop fever, pain, swelling, and erythema around the affected joint and, if untreated, these symptoms can progress to an established heterotopic ossification (HO) that can lead to joint stiffness or even ankylosis wherein the stiff or ankylosed hip joint is fixed in a non-functional position, which can impede nursing care, including hygiene care and obtaining a stable sitting posture. In advanced cases, NHO can lead to development of ulcers that can have additional adverse effects on the patients’ quality of life.

Despite various surgical complications, including excessive bleeding, infection, recurrence, binary fractures, and neurovascular damage, resection remains the only proven treatment for NHO5,6,14,15,16,17). Thus there are questions regarding the appropriateness of resection in management of NHO. The aim of this study was to evaluate the clinical outcome and safety of resection of ankylosed hip NHO in stroke patients.

MATERIALS AND METHODS

1. Participants

This study was approved by the Institutional Review Board (IRB) of Chonnam National University Hwasun Hospital (IRB No. CNUHH-2022-232). The written informed consent was waived by the IRB due to the retrospective nature of the study. This retrospective single-center cross-sectional study was conducted in order to examine the clinical outcomes and complications of surgical treatment of NHO performed at Chonnam National University Hwasun Hospital from 2010 to 2018. Patients who underwent resection of NHO that occurred after a cerebrovascular accident were included. Our surgical indications were patients who met both of the following conditions: (1) Patients with difficulty in wheelchair ambulation or perineal hygiene care because of an ankylosed hip due to HO, (2) HO is matured. The diagnosis was based on evidence of simple radiographic appearance following exoskeleton formation. A preoperative computed tomography (CT) scan with three-dimensional (3D) reconstruction was used for comprehensive surgical planning, followed by surgical resection of the exoskeleton.

2. Operative Method

All operations were performed by one of the two senior hip surgeons in Chonnam National University Hwasun Hospital. A thorough review of the CT scan was performed by the operating surgeon in order to determine the surgical approach. A Smith-Peterson approach was used in all cases included in this study. The hip joint capsule was preserved as much as possible. Differentiation from normal bone was sometimes impossible due to matured ectopic bone. Therefore, an image intensifier was used to guide the resection, which was halted after the desired functional range of motion had been obtained. Repair of the joint capsule was performed in cases of an unintentional breach. A negative-pressure drain was inserted in all cases to reduce the risk of postoperative hematoma formation. Postoperative monitoring of the hemoglobin level was performed.

For prevention of recurrence, adjuvant radiation therapy was performed within 24 hours after the operation if available. Patients also took etidronate or non-steroidal anti-inflammatory drugs (NSAIDs) medication postoperatively.

3. Follow-up

The patients were observed during follow-up, after the first and third months after discharge, and every six months thereafter. The range of motion was recorded during follow-up, and a plain radiograph of the hip was obtained to monitor for recurrence of HO.

4. Evaluation Methods

The following data were extracted from the electronic medical records of each patient: age, sex, side, location of NHO, severity of NHO according to Brooker grading18), previous history of the hip joint on the affected side such as history of other disease or operation, interval from time of neurological insult to time of resection surgery, and operation-related details, including operating surgeon, surgical approach used, duration of operation, and the maximum hemoglobin decrease within the first postoperative week. The pre- and postoperative range of motion of the operated hip were compared for determination of the clinical outcome and all postoperative complications were documented. Statistical analysis was performed using IBM SPSS Statistical software (ver. 25; IBM), and P<0.05 was considered statistically significant. A comparison of range of motion between the preoperative and postoperative period was performed using a Mann–Whitney test.

RESULTS

From 2010 to 2018, nine hip NHO resections were performed in seven patients (all patients were male); four resections were performed on the right hip and five on the left hip. The mean age of patients in our series was 51.44±9.42 years. All nine hip NHOs occurred after a cerebrovascular accident and none of the patients had previous history such as history of other disease or operation for the hip joint on the affected side. The mean duration of follow-up was 52.08±28.72 months. The mean interval from the cerebrovascular accident to NHO surgery was 36.27±25.61 months. According to the Brooker classification for HO, three cases of NHO were graded as Class III and six cases were graded as Class IV18). Regarding the location of the ectopic bone, all NHOs occurred at the anterior aspect of the hip along the iliopsoas muscle, and additional NHO was detected at the lateral aspect of the hip along the gluteus medius in one case. Details regarding the demographic distribution are shown in Table 1.

In the preoperative physical examination, only a limited range of motion of less than 30° in all motions of the hip joint was observed in seven out of nine cases. Ambulation was only possible in one case. Details regarding the preoperative range of motion and ambulation status are shown in Table 2.

CT scan images obtained preoperatively and plain radiographs obtained after sequential excision surgery in a representative case are shown in Fig. 1.

The mean operative time for NHO surgery was 132.78±21.08 minutes. The hemoglobin drop in the postoperative period was 3.06±0.82 g/dL in the first week. The amount of preoperative transfusion of packed red cells (PRC) was 3.89±2.71 packs, and one pack of PRC was 320 mL. The amount of heterotopic bone removed intraoperatively was 225.89±67.30 g. To prevent recurrence after the operation, all patients took NSAIDs medication per oral. In additional, radiation therapy was administered in two patients, two patients took etidronate medication per oral, two patients received both, and three patients did not receive either one. Detailed postoperative information is shown in Table 3.

The pre- and postoperative range of motion of the operated hip were compared in order to determine the primary outcome of our study. Details regarding the postoperative range of motion are shown in Table 4. Improvement of the total range of motion to 153.89±38.14° was observed postoperatively. The range of motion before and after surgery differed significantly, except for abduction range. Flexion and external rotation showed the most significant gains in range of motion, with mean improvements of 58.89±30.60° and 16.67±18.03°, respectively. This improved functional range of motion was particularly important for achievement of a stable sitting posture as well as for perineal hygiene care. Results on the improvement in the range of motion are shown in Table 5.

There were two cases of postoperative infection in our cohort. The first patient presented with wound dehiscence and oozing after transfer to the ward in the initial postoperative period. The hematoma was identified based on a CT scan (Fig. 2). The second patient presented with late erythema and swelling during subsequent follow-up, and a CT scan confirmed abscess formation with gas at the NHO resection site. In both cases, resolution of the complications was achieved after surgical debridement with insertion of a negative pressure drain and a short course of systemic antibiotics.

In addition, this cohort included one case of late joint instability and subluxation in a patient with relatively few limitations in the range of hip joint motion who was able to stand up with use of a walker during the preoperative physical examination. Despite the initial improvement in range of motion, the patient complained of slowly progressing pain over the operated hip. Progressive subluxation and osteoarthritic changes of the hip were observed on serial plain radiography during the follow-up. The patient underwent a total hip replacement surgery nine years after the initial NHO surgery, which resulted in resolution of the symptoms. There were no cases of recurrence, iatrogenic fracture, or neurovascular injury in our cohort.

DISCUSSION

Although extensive study has been conducted in recent years, the precise pathophysiology underlying the development of NHO remains unclear15,19), despite growing evidence of the induction of HO via the release of osteoconductive factors, produced by a complex interface between local and systemic conditions that includes the autonomous nervous system and inflammatory responses20,21). There is still no effective preventive intervention for NHO despite the use of a few widely accepted prophylactic methods, including NSAIDs, such as indomethacin and celecoxib22), and radiation therapy23,24). There are questions regarding the effectiveness of prophylactic treatments, and there is considerable variation in the dosage and dosing interval used in different centers.

In patients with established NHO, the limitation of the range of motion of the hip joint can have adverse effects on the patient’s quality of life, causing many difficulties in daily life. Thus far the only effective treatment is resection or total hip arthroplasty3,10,14,25), which, although efficient in recovery of motion in the NHO-involved hip joint, is technically demanding and is associated with a high risk of complications that include excessive bleeding, recurrence, infection, iatrogenic fracture, and neurovascular injuries17).

The earliest incidence of infection following NHO resection was reported by Garland and Orwin16) in 1989, wherein superficial or deep infection was detected postoperatively in 79% (19 out of 24) of operated hips. Two studies by Stover et al.26) and Meiners et al.5) reported postoperative infection rates of 9% and 12% in 42 and 41 hips, respectively. A more recent study by Gatin et al.4) in 2017 reported an overall postoperative infection rate of 10%, of which 22% of cases occurred in patients with spinal cord injury and 5% in patients with other causes of NHO. We observed a rate of postoperative infection of 22% in our study group, which is comparable to those reported by other authors.

Postoperative recurrence of HO is a problematic complication for the patients and can be worrisome for the treating surgeon. Garland and Orwin16) reported a recurrence rate of 86% in their study conducted in 1989, whereas Almangour et al.14) reported a much lower recurrence rate of 5.6% in their more recent study conducted in 2016. This wide range is the result of a lack of consensus on the definition of recurrence14). Waiting for the ectopic bone to mature prior to resection by monitoring the patient’s symptoms and the serial plain radiography is the common practice. Alternatively, bone scintigraphy, a sensitive examination for detecting HO, which is widely accepted as an effective method for determining the maturity of the ectopic bone, can facilitate planning of the excision timing27,28). However, according to findings from recent studies, the risk of recurrence is independent of the timing of surgery6,14,29). Early performance of an operation is feasible, and surgery should not be unduly delayed while waiting to observe a “cold” lesion on bone scintigraphy. In our series, bone scintigraphy was not performed to determine the maturity of the NHO, and resection was planned and performed as soon as NHO had caused significant functional interference in posture or the nursing process for the patient.

Nevertheless, development of a clear goal for each patient before the surgical removal of NHO is important. The targeted range of motion that should be achieved during the resection surgery should be determined by the operating surgeon. Thorough preoperative planning based on CT scans can guide the surgeon with regard to the target amount of ectopic bone to be removed to obtain the range of motion required for achievement of functional improvement. A complete resection of all ectopic bones, as used in the oncological approach, unnecessarily increases morbidity without additional advantage to the patient and should therefore be avoided15). Besides increasing the risk of bleeding, the resulting larger dead space can lead to hematoma formation and increased risk of infection. In addition, there may also be a risk of iatrogenic fracture or joint instability.

One case of late instability following NHO resection that eventually required a total hip replacement was identified in our cohort. We believe that the instability was a result of overzealous removal of ectopic bone, as matured ectopic bone is indistinguishable from the underlying normal bone3). Under the guidance of the image intensifier, assessment of the intraoperative range of motion by the operating surgeon is important, and resection should be halted when the desired range of motion has been achieved.

No cases of recurrence, iatrogenic fracture, or neurovascular injury were observed in our study group, which we attribute to use of meticulous surgical technique and conduct of detailed preoperative planning for each patient. It is interesting to note that our cohort includes two stroke patients with bilateral hip NHO. Development of NHO on the non-paretic side was uncommon and was barely discussed in case reports30), until a recent study published in 2019, wherein Cunha et al.10) reported an incidence of bilateral NHO of 0.2% in 17,794 stroke patients who were included in their study. In our study, to minimize the risk of excessive intraoperative bleeding, resection of bilateral hip NHO was performed in a sequential setting with an interval of 3-6 months.

One limitation of this study is the relatively small sample size, which can be attributed in part to the retrospective study design, as some of the patient data were missing and some patients were lost to follow-up. However, because only a few studies on NHO resection in stroke patients have been reported, we believe that the results of this study provide a framework for designing future studies and will be helpful in determining the policy for treating rare cases of NHO in stroke patients.

CONCLUSION

In conclusion, NHO resection in stroke patients is a beneficial and effective surgery for recovering functional range of motion of the hip and improving quality of life in patients with neurological disorders. To minimize the potential risk of operative complications, we recommend performance of a minimal resection surgery to achieve the desired functional range of motion over a complete removal of the ectopic bone.

CONFLICTS OF INTEREST

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.

Fig 1.

Figure 1.

(A, B) Preoperative plain radiograph and computed tomography scan of a stroke patient with left hip neurogenic heterotopic ossification. (C, D) Immediate operation plain radiograph and clinical photo of removed heterotopic ossification. (E) Follow-up plain radiograph taken one year after surgery.

Hip & Pelvis 2023; 35: 268-276https://doi.org/10.5371/hp.2023.35.4.268

Fig 2.

Figure 2.

(A) Preoperative plain radiograph of a stroke patient with bilateral hip neurogenic heterotopic ossification. (B) Immediate operation plain radiograph. (C, D) Computed tomography scan performed two weeks after surgery showing hematoma formation.

Hip & Pelvis 2023; 35: 268-276https://doi.org/10.5371/hp.2023.35.4.268
Demographic Distribution of NHO Patients
Case No.SexAge (yr)SideCausePHx of affected side hip jointFollow-up duration (mo)Interval to operation (mo)Brooker classificationHO locationSurgical approach
1M47RCVANone56.3048.73IVIliopsoas and gluteus mediusSmith-Peterson
2M47LCVANone58.8746.17IIIIliopsoasSmith-Peterson
3M61RCVANone40.2311.37IVIliopsoasSmith-Peterson
4M61LCVANone33.3318.27IVIliopsoasSmith-Peterson
5M42LCVANone24.6092.47IIIIliopsoasSmith-Peterson
6M36LCVANone122.7731.97IVIliopsoasSmith-Peterson
7M37RCVANone52.5044.87IVIliopsoasSmith-Peterson
8M48LCVANone39.1016.27IVIliopsoasSmith-Peterson
9M64RCVANone41.0016.33IIIIliopsoasSmith-Peterson
Mean51.44±9.4252.08±28.7236.27±25.61

NHO: neurogenic heterotopic ossification, M: male, R: right, L: left, CVA: cerebrovascular accident, PHx: past history, HO: heterotopic ossification..


Preoperative ROM and Ambulation Status of NHO Patients
Case No.Flexion (°)Extension (°)Internal rotation (°)External rotation (°)Abduction (°)Adduction (°)Total ROM (°)Ambulation status
130–30–2020000Wheelchair
230–3000000Wheelchair
310–10005510Bed-ridden
400005510Bed-ridden
5700010205105Ambulation with support
620–2000000Bed-ridden
760–3010010050Wheelchair
830–30–303015–150Wheelchair
9300040300105Wheelchair

ROM: range of motion, NHO: neurogenic heterotopic ossification..


Intraoperative and Postoperative Information of NHO Patients
Case No.Operation time (min)Hemoglobin drop (g/dL)PRC transfusion (pack)Resection amount (g)Postop RTPostop etidronatePostop NSAIDsComplication
11053.36320YesYesYesNone
21202.50190YesYesYesNone
31652.98220NoYesYesInfection
414037180NoNoYesNone
51603.12170NoNoYesNone
61451.54260YesNoYesNone
71253.44310YesNoYesInstability
81254.61263NoNoYesInfection
91103.23120NoYesYesNone
Mean132.78±21.083.06±0.823.89±2.71225.89±67.30

NHO: neurogenic heterotopic ossification, PRC: packed red cells, Postop: postoperative, RT: radiation therapy, NSAIDs: non-steroidal anti-inflammatory drugs..


Postoperative ROM of NHO Patients
Case No.Flexion (°)Extension (°)Internal rotation (°)External rotation (°)Abduction (°)Adduction (°)Total ROM (°)
1100010301020170
2110010301020180
390010303015185
49005303015180
5120010403010315
61000030200150
7600101005135
890051055115
95001040300230

ROM: range of motion, NHO: neurogenic heterotopic ossification..


Improvement in ROM of NHO Patients
PreoperativePostoperativeImprovementP-value
Flexion (°)31.11±22.0590.00±22.3658.89±30.600.000
Extension (°)–16.67±14.140.00±0.0016.67±14.140.014
Internal rotation (°)–4.44±12.367.78±3.6312.22±12.280.004
External rotation (°)11.11±15.3727.78±10.9316.67±18.030.024
Abduction (°)9.44±10.4418.33±12.258.89±13.410.136
Adduction (°)0.00±6.1210.00±7.9110.00±8.290.019
Total ROM (°)30.56±43.76184.44±58.97153.89±38.140.000

The P-values are of inter-group comparisons, with P<0.05 indicating significance..

ROM: range of motion, NHO: neurogenic heterotopic ossification..


References

  1. Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002;43:346-353.
    Pubmed
  2. Cipriano CA, Pill SG, Keenan MA. Heterotopic ossification following traumatic brain injury and spinal cord injury. J Am Acad Orthop Surg 2009;17:689-697.
    Pubmed CrossRef
  3. Brady RD, Shultz SR, McDonald SJ, O’Brien TJ. Neurological heterotopic ossification: current understanding and future directions. Bone 2018;109:35-42.
    Pubmed CrossRef
  4. Gatin L, Genêt F, Dinh A, Denormandie P. Postoperative infections after excision of neurogenic heterotopic ossifications at the hip: risk factors and causative organisms. Orthop Traumatol Surg Res 2017;103:357-361.
    Pubmed CrossRef
  5. Meiners T, Abel R, Böhm V, Gerner HJ. Resection of heterotopic ossification of the hip in spinal cord injured patients. Spinal Cord 1997;35:443-445.
    Pubmed CrossRef
  6. Denormandie P, de l’Escalopier N, Gatin L, Grelier A, Genêt F. Resection of neurogenic heterotopic ossification (NHO) of the hip. Orthop Traumatol Surg Res 2018;104:S121-S127.
    Pubmed CrossRef
  7. Genêt F, Minooee K, Jourdan C, Ruet A, Denormandie P, Schnitzler A. Troublesome heterotopic ossification and stroke: features and risk factors. A case control study. Brain Inj 2015;29:866-871.
    Pubmed CrossRef
  8. Hajek VE. Heterotopic ossification in hemiplegia following stroke. Arch Phys Med Rehabil 1987;68:313-314.
    Pubmed
  9. Varghese G, Williams K, Desmet A, Redford JB. Nonarticular complication of heterotopic ossification: a clinical review. Arch Phys Med Rehabil 1991;72:1009-1013.
    Pubmed CrossRef
  10. Cunha DA, Camargos S, Passos VMA, Mello CM, Vaz LS, Lima LRS. Heterotopic ossification after stroke: clinical profile and severity of ossification. J Stroke Cerebrovasc Dis 2019;28:513-520.
    Pubmed CrossRef
  11. van Kuijk AA, Geurts AC, van Kuppevelt HJ. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord 2002;40:313-326.
    Pubmed CrossRef
  12. Wharton GW, Morgan TH. Ankylosis in the paralyzed patient. J Bone Joint Surg Am 1970;52:105-112.
    Pubmed
  13. Allard MM, Thomas RL, Nicholas RW. Myositis ossificans: an unusual presentation in the foot. Foot Ankle Int 1997;18:39-42.
    Pubmed CrossRef
  14. Almangour W, Schnitzler A, Salga M, Debaud C, Denormandie P, Genêt F. Recurrence of heterotopic ossification after removal in patients with traumatic brain injury: a systematic review. Ann Phys Rehabil Med 2016;59:263-269.
    Pubmed CrossRef
  15. de l’Escalopier N, Salga M, Gatin L, Genêt F, Denormandie P. Resection of heterotopic ossification around the hip after trauma. EFORT Open Rev 2019;4:263-268.
    Pubmed CrossRef
  16. Garland DE, Orwin JF. Resection of heterotopic ossification in patients with spinal cord injuries. Clin Orthop Relat Res 1989;:169-176.
  17. Macheras GA, Lepetsos P, Leonidou A, Anastasopoulos PP, Galanakos SP, Tsiridis E. Results from the surgical resection of severe heterotopic ossification of the hip: a case series of 26 patients. Eur J Orthop Surg Traumatol 2017;27:1097-1102.
    Pubmed CrossRef
  18. Brooker AF, Bowerman JW, Robinson RA, Riley LH. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973;55:1629-1632.
    Pubmed
  19. Genêt F, Kulina I, Vaquette C, et al. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle. J Pathol 2015;236:229-240.
    Pubmed CrossRef
  20. Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 1990;72:1144-1149.
    Pubmed CrossRef
  21. Sullivan MP, Torres SJ, Mehta S, Ahn J. Heterotopic ossification after central nervous system trauma: a current review. Bone Joint Res 2013;2:51-57.
    Pubmed CrossRef
  22. Baird EO, Kang QK. Prophylaxis of heterotopic ossification - an updated review. J Orthop Surg Res 2009;4:12.
    Pubmed CrossRef
  23. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys 2006;65:1289-1299.
    Pubmed CrossRef
  24. Pellegrini VD, Gregoritch SJ. Preoperative irradiation for prevention of heterotopic ossification following total hip arthroplasty. J Bone Joint Surg Am 1996;78:870-881.
    Pubmed CrossRef
  25. Genêt F, Jourdan C, Schnitzler A, et al. Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries. PLoS One 2011;6:e16632.
    Pubmed CrossRef
  26. Stover SL, Niemann KM, Tulloss JR. Experience with surgical resection of heterotopic bone in spinal cord injury patients. Clin Orthop Relat Res 1991;:71-77.
  27. Tyler JL, Derbekyan V, Lisbona R. Early diagnosis of myositis ossificans with Tc-99 m diphosphonate imaging. Clin Nucl Med 1984;9:256-258.
    Pubmed CrossRef
  28. Drane WE. Myositis ossificans and the three-phase bone scan. AJR Am J Roentgenol 1984;142:179-180.
    Pubmed CrossRef
  29. Genêt F, Ruet A, Almangour W, Gatin L, Denormandie P, Schnitzler A. Beliefs relating to recurrence of heterotopic ossification following excision in patients with spinal cord injury: a review. Spinal Cord 2015;53:340-344.
    Pubmed CrossRef
  30. Kocaağa Z, Bal S, Gurgan A. Hemiplegia and heterotopic ossification on the non-paretic extremity: a case report. J Rehabil Med 2007;39:500-502.
    Pubmed CrossRef

Share this article on

  • line

Related articles in H&P

Hip & Pelvis